329 related articles for article (PubMed ID: 37525495)
1. The Gut-Heart Axis: Updated Review for The Roles of Microbiome in Cardiovascular Health.
Bui TVA; Hwangbo H; Lai Y; Hong SB; Choi YJ; Park HJ; Ban K
Korean Circ J; 2023 Aug; 53(8):499-518. PubMed ID: 37525495
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease.
Wen Y; Sun Z; Xie S; Hu Z; Lan Q; Sun Y; Yuan L; Zhai C
J Multidiscip Healthc; 2022; 15():2591-2603. PubMed ID: 36388628
[TBL] [Abstract][Full Text] [Related]
3. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota.
Alhajri N; Khursheed R; Ali MT; Abu Izneid T; Al-Kabbani O; Al-Haidar MB; Al-Hemeiri F; Alhashmi M; Pottoo FH
Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683334
[TBL] [Abstract][Full Text] [Related]
5. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
6. The gut-immune axis during hypertension and cardiovascular diseases.
Dinakis E; O'Donnell JA; Marques FZ
Acta Physiol (Oxf); 2024 Jun; ():e14193. PubMed ID: 38899764
[TBL] [Abstract][Full Text] [Related]
7. Understanding connections and roles of gut microbiome in cardiovascular diseases.
Rajendiran E; Ramadass B; Ramprasath V
Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
[TBL] [Abstract][Full Text] [Related]
8. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and cardiovascular diseases axis.
Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review).
Zhu Y; Shui X; Liang Z; Huang Z; Qi Y; He Y; Chen C; Luo H; Lei W
Int J Mol Med; 2020 Sep; 46(3):936-948. PubMed ID: 32705240
[TBL] [Abstract][Full Text] [Related]
11. Implications of gut microbiome on coronary artery disease.
Xu J; Yang Y
Cardiovasc Diagn Ther; 2020 Aug; 10(4):869-880. PubMed ID: 32968642
[TBL] [Abstract][Full Text] [Related]
12. Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats.
Li L; Zhong SJ; Hu SY; Cheng B; Qiu H; Hu ZX
BMC Microbiol; 2021 May; 21(1):141. PubMed ID: 33952214
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases.
Xu J; Yang Y
Gut Microbes; 2021; 13(1):1936379. PubMed ID: 34170211
[TBL] [Abstract][Full Text] [Related]
14. Gut microbes in cardiovascular diseases and their potential therapeutic applications.
Jin L; Shi X; Yang J; Zhao Y; Xue L; Xu L; Cai J
Protein Cell; 2021 May; 12(5):346-359. PubMed ID: 32989686
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic activities of succinate: The interplay between gut microbiota and cardiovascular diseases.
Xu J; Yang Y; Li X; Ding S; Zheng L; Xiong C; Yang Y
Imeta; 2023 Aug; 2(3):e124. PubMed ID: 38867936
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.
Usman I; Anwar A; Shukla S; Pathak P
Cardiovasc Hematol Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38879769
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
18. The role of intestinal microbiota in cardiovascular disease.
Jin M; Qian Z; Yin J; Xu W; Zhou X
J Cell Mol Med; 2019 Apr; 23(4):2343-2350. PubMed ID: 30712327
[TBL] [Abstract][Full Text] [Related]
19. Probiotics, gut microbiome, and cardiovascular diseases: An update.
Dosh L; Ghazi M; Haddad K; El Masri J; Hawi J; Leone A; Basset C; Geagea AG; Jurjus R; Jurjus A
Transpl Immunol; 2024 Apr; 83():102000. PubMed ID: 38262540
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
Ahmad AF; Dwivedi G; O'Gara F; Caparros-Martin J; Ward NC
Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H923-H938. PubMed ID: 31469291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
